Is Qiagen NV Stock a Good Investment?
Qiagen NV Investment Advice | QGEN |
- Examine Qiagen NV's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Qiagen NV's leadership team and their track record. Good management can help Qiagen NV navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceutical Products space and any emerging trends that could impact Qiagen NV's business and its evolving consumer preferences.
- Compare Qiagen NV's performance and market position to its competitors. Analyze how Qiagen NV is positioned in terms of product offerings, innovation, and market share.
- Check if Qiagen NV pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Qiagen NV's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Qiagen NV stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Qiagen NV is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Qiagen NV Stock
Researching Qiagen NV's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 64.0% of the company shares are owned by institutional investors. The book value of Qiagen NV was at this time reported as 16.05. The company has Price/Earnings To Growth (PEG) ratio of 0.92. Qiagen NV last dividend was issued on the 29th of January 2025. The entity had 962:1000 split on the 25th of January 2017.
To determine if Qiagen NV is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Qiagen NV's research are outlined below:
| Qiagen NV generated a negative expected return over the last 90 days | |
| About 64.0% of the company shares are owned by institutional investors |
Qiagen NV uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Qiagen NV. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Qiagen NV's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Qiagen NV's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.59 B.Qiagen NV's profitablity analysis
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.28 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.28.Determining Qiagen NV's profitability involves analyzing its financial statements and using various financial metrics to determine if Qiagen NV is a good buy. For example, gross profit margin measures Qiagen NV's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Qiagen NV's profitability and make more informed investment decisions.
Basic technical analysis of Qiagen Stock
As of the 20th of March, Qiagen NV holds the Coefficient Of Variation of (803.99), variance of 2.29, and Risk Adjusted Performance of (0.11). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Qiagen NV, as well as the relationship between them.Qiagen NV's Outstanding Corporate Bonds
Qiagen NV issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Qiagen NV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Qiagen bonds can be classified according to their maturity, which is the date when Qiagen NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Qiagen NV's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Qiagen NV's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | 1.37 | |||
| Mean Deviation | 1.13 | |||
| Coefficient Of Variation | (803.99) | |||
| Standard Deviation | 1.51 | |||
| Variance | 2.29 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.07) | |||
| Treynor Ratio | 1.36 | |||
| Maximum Drawdown | 6.36 | |||
| Value At Risk | (3.00) | |||
| Potential Upside | 2.59 | |||
| Skewness | 0.21 | |||
| Kurtosis | 0.168 |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | 1.37 | |||
| Mean Deviation | 1.13 | |||
| Coefficient Of Variation | (803.99) | |||
| Standard Deviation | 1.51 | |||
| Variance | 2.29 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.07) | |||
| Treynor Ratio | 1.36 | |||
| Maximum Drawdown | 6.36 | |||
| Value At Risk | (3.00) | |||
| Potential Upside | 2.59 | |||
| Skewness | 0.21 | |||
| Kurtosis | 0.168 |
Consider Qiagen NV's intraday indicators
Qiagen NV intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Qiagen NV stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Qiagen NV time-series forecasting models is one of many Qiagen NV's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Qiagen NV's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Qiagen Stock media impact
Far too much social signal, news, headlines, and media speculation about Qiagen NV that are available to investors today. That information is available publicly through Qiagen media outlets and privately through word of mouth or via Qiagen internal channels. However, regardless of the origin, that massive amount of Qiagen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Qiagen NV news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Qiagen NV relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Qiagen NV's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Qiagen NV alpha.
Qiagen NV Corporate Management
| John Gilardi | VP of Corporate Communications and Investor Relations | Profile | |
| Stephane Bancel | Independent Member of the Supervisory Board | Profile | |
| Fernando Beils | Senior Area | Profile | |
| JeanPascal Viola | Senior Development | Profile | |
| Elaine Mardis | Independent Member of the Supervisory Board | Profile | |
| Thomas Ebeling | Independent Member of the Supervisory Board | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Qiagen NV's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Qiagen NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.